News

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...
Her doctor prescribed an antidepressant, even though the then 36-year-old insisted she wasn’t depressed. She even went to ...
On Thursday in Washington, D.C., the U.S. Food and Drug Administration (FDA) convened a panel of top experts to reassess the ...
The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...
A panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.
Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...
FDA To Address Hormone Therapy. By Robin Wood. August 14, 2002 / 3:34 PM EDT / CBS A ... stroke and heart disease from long-term use of one type of popular drug. ...
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...